Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients. - Parfrey PS; Burke SK; Chertow GM; Eckardt KU; Jardine AG; Lewis EF; Luo W; Matsushita K; McCullough PA; Minga T; Winkelmayer WC (Kidney medicine, 2023)